Research programme: polymeric nano-delivery system therapeutics - Labopharm

Drug Profile

Research programme: polymeric nano-delivery system therapeutics - Labopharm

Alternative Names: DDS-04F; DDS-06E; Propofol - Labopharm; SN38

Latest Information Update: 16 Jul 2016

Price : $50

At a glance

  • Originator Labopharm
  • Developer Altus Formulation Inc
  • Class Camptothecins; Phenols
  • Mechanism of Action DNA topoisomerase I inhibitors; GABA receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • Available For Licensing Yes

Highest Development Phases

  • No development reported Anaesthesia; Colorectal cancer

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for preclinical development in Anaesthesia in Canada (IV, Liquid)
  • 16 Jul 2016 No recent reports of development identified for preclinical development in Colorectal-cancer in Canada (PO)
  • 28 Feb 2014 Endo Health Solutions and Paladin Labs combine to form Endo International
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top